Air Canada
TSX-AC
Company Overview
Air Canada provides domestic, U.S. transborder, and international airline services. It offers scheduled passenger services under the Air Canada Vacations and Air Canada Rouge brand name in the Canadian market, the Canada-U.S. transborder market, and in the international market to and from Canada, as well as through capacity purchase agreements on other regional carriers. As of December 31, 2021, the company operated a fleet of 175 aircraft under the Air Canada mainline brand name comprising 97 Boeing and Airbus narrow-body aircraft, and 78 Boeing and Airbus wide-body aircraft; 123 aircraft under the Air Canada Express brand name, including 50 Mitsubishi regional jets, 48 De Havilland Dash-8 turboprop aircraft and 25 Embraer 175 aircraft; and 39 aircraft under the Air Canada Rouge brand name consisting of 14 Airbus A321 aircraft, 5 Airbus A320 aircraft, and 20 Airbus A319 aircraft. It also provides air cargo services in domestic and U.S. transborder routes, as well as on international routes between Canada and markets in Europe, Asia, South America, and Australia. In addition, the company operates, develops, markets, and distributes vacation travel packages in the Caribbean, Mexico, the United States, Europe, Central and South America, South Pacific, Australia, and Asia; offers cruise packages in North America, Europe, and the Caribbean; and provides travel loyalty programs. Air Canada was founded in 1937 and is headquartered in Saint-Laurent, Canada.
Name
Air Canada
CEO
Mr. Michael Stewart Rousseau
Website
www.aircanada.com
Sector
Passenger Airlines
Year Founded
1937
Profile
Market Cap
CA$5,879.29M
EV
CA$10.22B
Shares Out
358.49M
Revenue
CA$22.26B
Employees
37,100
Margins
Gross
32.16%
EBITDA
13.98%
Operating
9.05%
Pre-Tax
7.99%
Net
7.92%
FCF
10.38%
Returns (5Yr Avg)
ROA
-4.54%
ROTA
58.55%
ROE
54.05%
ROCE
-2.47%
ROIC
-2.44%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
CA$22.65
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
CA$8,132M
Net Debt
CA$4,345M
Debt/Equity
10.71
EBIT/Interest
2.4
Growth (CAGR)
Rev 3Yr
91.91%
Rev 5Yr
3.47%
Rev 10Yr
5.74%
Dil EPS 3Yr
-30.64%
Dil EPS 5Yr
3.83%
Dil EPS 10Yr
22.45%
Rev Fwd 2Yr
3.37%
EBITDA Fwd 2Yr
-4.68%
EPS Fwd 2Yr
-21.61%
EPS LT Growth Est
-44.81%
Dividends
Yield
—
Payout
—
DPS
—
DPS Growth 3Yr
—
DPS Growth 5Yr
—
DPS Growth 10Yr
—
DPS Growth Fwd 2Yr
—